Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/1992
04/07/1992US5102878 Treating psychological, bone, cardiovascular, blood disorders
04/07/1992US5102877 Carbapenicillin antibiotics
04/07/1992US5102869 Urogenital disorders
04/07/1992US5102791 Stable sulpho-adendoyl-l-methionine (same) salts, particlarly suitable for parenteral use
04/07/1992US5102670 Antiwelling agent
04/07/1992US5102667 Antiallergens, antiinflammatory agents, nervous system disorders, immunology, psychological disorders
04/07/1992US5102665 Pharmaceutical compositions
04/07/1992CA1298582C Benzo-(pyrano and thiopyrano)-¬3,4-b|pyridine compounds
04/07/1992CA1298580C ¬¬¬(3-pyridinyl)methylen|amino|oxy|alkanoic acids and esters
04/07/1992CA1298558C Pharmacological/cosmetic preparation containing plant extracts
04/07/1992CA1298536C Assay for sulfhydryl amino acids and methods for detecting and distinguishing cobalamin and folic acid deficiency
04/06/1992WO1992005779A1 Method of administering amiloride
04/06/1992WO1992005769A1 Prevention or treatment of sunburn using the s(+) isomer of ketoprofen
04/06/1992CA2093359A1 Prevention or treatment of sunburn using the s(+) isomer of ketoprofen
04/06/1992CA2093233A1 Method of administering amiloride
04/06/1992CA2052494A1 Animal growth promotion
04/06/1992CA2052425A1 2-(3-pyridyl)-carbapenem antibacterial agents
04/05/1992WO1992006098A1 Acidic polycyclic ether antibiotic
04/05/1992WO1992005790A1 Use of a heparinfraction
04/05/1992WO1992005763A1 Composition containing steroid derivatives
04/05/1992CA2093357A1 Heparin fraction
04/05/1992CA2093349A1 Composition containing steroid derivatives
04/05/1992CA2091567A1 Acidic polycyclic ether antibiotic
04/05/1992CA2052726A1 3- piperazinosydnone imines, process for their preparation and their use
04/05/1992CA2052294A1 Heterocyclic acids
04/04/1992WO1992006089A1 Sertindole prodrugs
04/04/1992WO1992006088A1 Indole derivatives as antiallergy and antiinflammatory agents
04/04/1992CA2092404A1 Indole derivatives as antiallergy and antiinflammatory agents
04/04/1992CA2052619A1 Piperazine derivatives
04/03/1992WO1992006102A1 Nucleoside derivatives
04/03/1992WO1992001679A1 1,4-disubstituted piperazines
04/03/1992CA2093020A1 Nucleoside derivatives
04/03/1992CA2052609A1 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their use in therapy
04/03/1992CA2051978A1 The preparation of stable injectable .beta.-carotene solubilizates
04/02/1992WO1992006180A1 Targeting viruses and cells for selective internalization by cells
04/02/1992WO1992006091A1 Anticoccidial and growth promoting polycyclic ether antibiotic
04/02/1992WO1992006068A1 High affinity tamoxifen derivatives and uses thereof
04/02/1992WO1992005287A1 Enzymatic synthesis of oligonucleotides
04/02/1992WO1992005190A1 Deoxyhypusyl hydroxylase inhibitors
04/02/1992WO1992005184A1 A non-mitogenic competitive hgf antagonist
04/02/1992WO1992005180A1 Heterocyclic compounds
04/02/1992WO1992005179A1 Carboxylic acid esters of rapamycin
04/02/1992WO1992005177A1 Compounds having antihypertensive and anti-ischemic properties
04/02/1992WO1992005174A1 3,9-diazabicyclo (3.3.1) nonan-7-yl derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
04/02/1992WO1992005170A1 Indole ureas as 5 ht receptor antagonist
04/02/1992WO1992005169A1 (2-thienyl) alkylamine derivatives having neuroprotective properties
04/02/1992WO1992005160A1 4-arylsulfonyl-3,4-dihydro-2(1h)-quinoxalinone-1-alkanoic acids, esters, and salts
04/02/1992WO1992005157A1 Peri-condensed benzazepines
04/02/1992WO1992005147A1 New process for preparing formoterol and related compounds
04/02/1992WO1992005145A1 Disubstituted aryl compounds exhibiting selective leukotriene b4 antagonist activity
04/02/1992WO1992005143A1 Anti-hypertensive tetralins
04/02/1992WO1992005130A1 NOVEL 1α-HYDROXY VITAMIN D4 AND NOVEL INTERMEDIATES AND ANALOGUES
04/02/1992WO1992004904A1 Dextrin sulfates as anti hiv-1 agents and composition thereof
04/02/1992WO1992004903A1 Method of inhibiting viral production
04/02/1992WO1992004901A1 Uracil reductase inactivators
04/02/1992WO1992004900A1 New use of fipexide
04/02/1992WO1992004898A1 Use of pyridylmethylsulphinyl-1h-benzimidazole derivates in the treatment of illnesses caused by helicobacter bacteria
04/02/1992WO1992004894A1 Antirheumatic
04/02/1992WO1992004893A1 Non-aqueous liquid oral suspensions
04/02/1992WO1992004892A1 Use of nabumetone against calcium depletion
04/02/1992WO1992004826A1 Pyruvate solutions to counteract acute renal failure
04/02/1992WO1991018606A3 Orally active nonaddicting analgesics
04/02/1992DE4131276A1 New metoclopramide salt compsns. with no additives - for use in treatment of vomiting, nausea and in regulation of gastrointestinal motility
04/02/1992CA2390654A1 Uracil reductase inactivators
04/02/1992CA2092996A1 High affinity tamoxifen derivatives and uses thereof
04/02/1992CA2092323A1 Targeting viruses and cells for selective internalization by cells
04/02/1992CA2052544A1 Substituted thieno [2,3-b] [1,4] thiazine-6-sulfonamides as antiglaucoma agents
04/02/1992CA2052517A1 Imidazole angiotensin ii antagonists incorporating acidic functional groups
04/02/1992CA2052510A1 4- or 5-substituted pyridine-2-carboxylic acids, a process for the preparation thereof and the use thereof as pharmaceuticals
04/02/1992CA2052509A1 4- or 5- substituted pyridine-2-carboxylic acids, a process for the preparation thereof and the use thereof as pharmaceuticals
04/02/1992CA2052507A1 Substituted pyridopyrimidinones and related heterocycles as angiotensin ii antagonists
04/02/1992CA2052438A1 Method to reduce intraocular pressure without causing miosis
04/02/1992CA2046527A1 3-substituted-aminomethyl-3-substituted-oxy-17a-methyl-17a-lower-alkyl-17a-aza-d-homo-5-alpha androstanes
04/01/1992EP0478456A1 Antifungal composition in dry aerosol form
04/01/1992EP0478446A1 Heterocyclic alkylamines, process for their preparation and pharmaceutical compositions containing them
04/01/1992EP0478416A1 Use of triazine- and pyrimidine derivatives for the preparation of medicaments reversing the resistance to anticancer and antimalarial agents
04/01/1992EP0478363A2 Novel sulfonamide fibrinogen receptor antagonists
04/01/1992EP0478362A2 Fibrinogen receptor antagonists
04/01/1992EP0478328A1 Novel fibrinogen receptor antagonists
04/01/1992EP0478292A1 Heterocyclic compounds
04/01/1992EP0478068A2 New process for making 17-beta alkanoyl 3-oxo-4-aza-5-alpha-androst-1-enes
04/01/1992EP0478065A2 New intermediate for making 3-oxo-4-aza-androst-1-ene 17beta-ketones
04/01/1992EP0478064A2 Microbial preparation of 13beta-13-deoxy-22,23-dihydro avermectin-B1a/B1b aglycone
04/01/1992EP0478061A1 Antiviral agent
04/01/1992EP0478001A1 Benzophenone oxime derivatives, pharmaceutical compositions and use
04/01/1992EP0477968A1 Extract from Ginkgo biloba leaves, in particular for intravenous injection or infusion, a method of preparation of the extract and ampoule preparations containing the extract
04/01/1992EP0477943A1 Topical powder composition containing cyclic AMP derivative
04/01/1992EP0477927A1 Sebaceous excitosecretory agent
04/01/1992EP0477903A2 Substituted-4-amino-3-pyridinols, a process for their preparation and their use as medicaments
04/01/1992EP0477871A2 Antiviral composition, containing guanine derivatives
04/01/1992EP0477819A2 Benzimidazole derivatives, their preparation and use
04/01/1992EP0477778A2 Benzene, pyridine and pyrimidine derivative
04/01/1992EP0477717A2 New 3-substituted cephalosporins, process for their preparation and their use as medicinal preparations
04/01/1992EP0477625A1 Method for preventing or treating anxiety employing a combination of an ace inhibitor and a drug that acts at serotonin receptors
04/01/1992EP0477624A1 Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors
04/01/1992EP0477552A1 Use of 10-membered ring lactones as lipid regulators
04/01/1992EP0477508A1 Improved oligosaccharide conjugate vaccines
04/01/1992EP0477454A1 Novel phosphonate derivatives of certain nucleosides
04/01/1992EP0477289A1 Anhydrous oil-based liquid suspension for delivering a medicament
04/01/1992EP0477270A1 Prevention and treatment of microbial infection by phosphoglycerides